These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25114502)

  • 1. Artificial tears potpourri: a literature review.
    Moshirfar M; Pierson K; Hanamaikai K; Santiago-Caban L; Muthappan V; Passi SF
    Clin Ophthalmol; 2014; 8():1419-33. PubMed ID: 25114502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye.
    Cömez AT; Tufan HA; Kocabıyık O; Gencer B
    Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops.
    Ousler GW; Michaelson C; Christensen MT
    Cornea; 2007 Sep; 26(8):949-52. PubMed ID: 17721294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of artificial tears on visual performance in subjects with dry eye.
    Ridder WH; Tomlinson A; Paugh J
    Optom Vis Sci; 2005 Sep; 82(9):835-42. PubMed ID: 16189494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous serum eye drops for dry eye.
    Pan Q; Angelina A; Zambrano A; Marrone M; Stark WJ; Heflin T; Tang L; Akpek EK
    Cochrane Database Syst Rev; 2013 Aug; 8(8):CD009327. PubMed ID: 23982997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?
    Essa L; Laughton D; Wolffsohn JS
    Cont Lens Anterior Eye; 2018 Feb; 41(1):60-68. PubMed ID: 28811095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
    Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
    Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Punctal occlusion for dry eye syndrome.
    Ervin AM; Law A; Pucker AD
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006775. PubMed ID: 28649802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial.
    Simmons PA; Carlisle-Wilcox C; Chen R; Liu H; Vehige JG
    Clin Ther; 2015 Apr; 37(4):858-68. PubMed ID: 25659956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of ferning patterns of lubricant eye drops mixed with various electrolytes and carboxymethylcellulose.
    Masmali AM
    Cont Lens Anterior Eye; 2019 Dec; 42(6):633-639. PubMed ID: 31010720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tear osmolarity measurements in dry eye related to primary Sjögren's syndrome.
    Utine CA; Bıçakçıgil M; Yavuz S; Çiftçi F
    Curr Eye Res; 2011 Aug; 36(8):683-90. PubMed ID: 21780917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of the ocular surface to treat dysfunctional tear syndrome associated with computer use.
    Yee RW; Sperling HG; Kattek A; Paukert MT; Dawson K; Garcia M; Hilsenbeck S
    Ocul Surf; 2007 Oct; 5(4):308-15. PubMed ID: 17938840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye.
    Jacobi C; Kruse FE; Cursiefen C
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):598-603. PubMed ID: 22813209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose.
    Cohen S; Martin A; Sall K
    Clin Ophthalmol; 2014; 8():157-64. PubMed ID: 24403819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel formulation of glycerin 1% artificial tears extends tear film break-up time compared with Systane lubricant eye drops.
    Gensheimer WG; Kleinman DM; Gonzalez MO; Sobti D; Cooper ER; Smits G; Loxley A; Mitchnick M; Aquavella JV
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):473-8. PubMed ID: 22554205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the short-term effect of artificial tears on contrast sensitivity in patients with Sjögren's syndrome.
    Zhang Y; Potvin R; Gong L
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):7977-82. PubMed ID: 24159086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome.
    Yoon KC; Park CS; You IC; Choi HJ; Lee KH; Im SK; Park HY; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):643-50. PubMed ID: 19850844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome.
    Kim M; Kim HS; Na KS
    Korean J Ophthalmol; 2017 Feb; 31(1):25-31. PubMed ID: 28243020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.